Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based ...

Recognizing the urgent need for intervention, a panel of experts has released new guidelines specifically for screening and ...

Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...

Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

Drinkers face another hike in the cost of alcohol under plans for a ramping-up of the SNP's controversial minimum pricing ...

Women with cirrhosis might notice their belly becoming swollen or bloated. This swelling is called ascites and happens ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...

In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...